Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008
about
Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011National trends in psychotropic medication use in young children: 1994-2009Is Metabolic Syndrome On the Radar? Improving Real-Time Detection of Metabolic Syndrome and Physician Response by Computerized Scan of the Electronic Medical RecordADHD pharmacogenetics across the life cycle: New findings and perspectives.Asperger's syndrome: diagnosis, comorbidity and therapy.The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical research.Prescriptions, nonmedical use, and emergency department visits involving prescription stimulants.Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.
P2860
Q28304087-002BAFFB-C46E-4DC3-B125-5F70A4BC2D2CQ33819699-46A884C0-AD16-4FDD-A696-080BA5330F41Q36921831-1ED5B74F-E9BE-4A38-9BAB-8EE408659697Q38209972-72A62751-3B8D-4887-988A-C8F29E5DA059Q38345718-FD91705D-43CD-4676-8AF9-85CFF5D9DB77Q38362252-3D835B8A-9FCC-46D1-AAF9-181F15924292Q38906464-8274BFF4-54F2-4BC8-861F-B18131477F9FQ47653552-207E3935-A407-45B7-9CE4-DC35CCC8225C
P2860
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008
@ast
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008
@en
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008
@nl
type
label
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008
@ast
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008
@en
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008
@nl
prefLabel
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008
@ast
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008
@en
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008
@nl
P2093
P2860
P1433
P1476
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008
@en
P2093
Ashley S Higashi
Craig F Garfield
E Ray Dorsey
G Caleb Alexander
Haiden A Huskamp
Rachel Kornfield
Rena M Conti
Stacie B Dusetzina
Sydeaka Watson
P2860
P304
P356
10.1176/APPI.PS.201200147
P407
P577
2013-04-01T00:00:00Z